0001104659-16-108205.txt : 20160329
0001104659-16-108205.hdr.sgml : 20160329
20160329115423
ACCESSION NUMBER: 0001104659-16-108205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160329
FILED AS OF DATE: 20160329
DATE AS OF CHANGE: 20160329
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ADAMS STREET PARTNERS LLC
CENTRAL INDEX KEY: 0001193586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 161534331
MAIL ADDRESS:
STREET 1: ONE NORTH WACKER DRIVE
STREET 2: STE 2200
CITY: CHICAGO
STATE: IL
ZIP: 60606-2807
4
1
a4.xml
4
X0306
4
2016-03-29
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001193586
ADAMS STREET PARTNERS LLC
ONE NORTH WACKER, SUITE 2200
CHICAGO
IL
60606
0
0
1
0
Common Stock, $0.0001 par value
2016-03-29
4
C
0
550864
A
550864
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
92278
A
643142
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
P
0
51712
15.00
A
694854
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
567121
A
567121
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
95001
A
662122
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
P
0
53239
15.00
A
715361
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
428998
A
428998
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
71863
A
500861
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
P
0
40272
15.00
A
541133
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
583510
A
583510
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
C
0
97746
A
681256
I
By Fund
Common Stock, $0.0001 par value
2016-03-29
4
P
0
54777
15.00
A
736033
I
By Fund
Series A Convertible Preferred Stock
2016-03-29
4
C
0
550864
D
Common Stock
550864
0
I
By Fund
Series B Convertible Preferred Stock
2016-03-29
4
C
0
92278
D
Common Stock
92278
0
I
By Fund
Series A Convertible Preferred Stock
2016-03-29
4
C
0
567121
D
Common Stock
567121
0
I
By Fund
Series B Convertible Preferred Stock
2016-03-29
4
C
0
95001
D
Common Stock
95001
0
I
By Fund
Series A Convertible Preferred Stock
2016-03-29
4
C
0
428998
D
Common Stock
428998
0
I
By Fund
Series B Convertible Preferred Stock
2016-03-29
4
C
0
71863
D
Common Stock
71863
0
I
By Fund
Series A Convertible Preferred Stock
2016-03-29
4
C
0
583510
D
Common Stock
583510
0
I
By Fund
Series B Convertible Preferred Stock
2016-03-29
4
C
0
97746
D
Common Stock
97746
0
I
By Fund
The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis at the consummation of Issuer's initial public offering.
Represents shares held directly by Adams Street 2011 Direct Fund LP ("AS 2011"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2011, may be deemed to beneficially own the shares held by AS 2011. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2011. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2011 except to the extent of their pecuniary interest therein.
Represents shares held directly by Adams Street 2012 Direct Fund LP ("AS 2012"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2012, may be deemed to beneficially own the shares held by AS 2012. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2012. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2012 except to the extent of their pecuniary interest therein.
Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein.
Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein.
The expiration date is not relevant to the conversion of these securities.
AS 2011, AS 2012, AS 2013 and AS 2014 purchased an aggregate of 200,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share.
/s/ Sara Robinson Dasse
2016-03-29